ReviewEClinicalMedicine2023

Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017-2022.

Chenghao Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.